HN2012000437A - Nuevos agentes anticancer y la preparacion de dichos agentes - Google Patents

Nuevos agentes anticancer y la preparacion de dichos agentes

Info

Publication number
HN2012000437A
HN2012000437A HN2012000437A HN2012000437A HN2012000437A HN 2012000437 A HN2012000437 A HN 2012000437A HN 2012000437 A HN2012000437 A HN 2012000437A HN 2012000437 A HN2012000437 A HN 2012000437A HN 2012000437 A HN2012000437 A HN 2012000437A
Authority
HN
Honduras
Prior art keywords
agents
preparation
new anticancer
anticancer agents
new
Prior art date
Application number
HN2012000437A
Other languages
English (en)
Inventor
Alain Commercon
Laurence Gauzy-Lazo
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of HN2012000437A publication Critical patent/HN2012000437A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/06—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 containing at least one condensed beta-lactam ring system, provided for by groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00, e.g. a penem or a cepham system

Abstract

LA INVENCION SE REFIERE A NUEVOS CONJUGADOS DE DIMEROS DE PIRROLO 1,4 BENZODIAZEPINA QUE PUEDEN SER UTILIZADOS COMO COMPUESTOS ANTICANCEROSOS.
HN2012000437A 2009-08-25 2012-02-24 Nuevos agentes anticancer y la preparacion de dichos agentes HN2012000437A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0904043A FR2949469A1 (fr) 2009-08-25 2009-08-25 Derives anticancereux, leur preparation et leur application en therapeutique
FR0904368A FR2949470B1 (fr) 2009-08-25 2009-09-11 Derives anticancereux, leur preparation et leur application therapeutique

Publications (1)

Publication Number Publication Date
HN2012000437A true HN2012000437A (es) 2015-03-02

Family

ID=41720559

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2012000437A HN2012000437A (es) 2009-08-25 2012-02-24 Nuevos agentes anticancer y la preparacion de dichos agentes

Country Status (33)

Country Link
US (2) US8481042B2 (es)
EP (1) EP2470547B1 (es)
JP (1) JP5889189B2 (es)
KR (1) KR20130026405A (es)
CN (1) CN102753559B (es)
AR (1) AR078143A1 (es)
AU (1) AU2010288382B2 (es)
BR (1) BR112012004146A2 (es)
CA (1) CA2772102C (es)
CL (2) CL2012000489A1 (es)
CO (1) CO6612210A2 (es)
CR (1) CR20120085A (es)
DO (1) DOP2012000038A (es)
EA (1) EA026488B1 (es)
EC (1) ECSP12011688A (es)
ES (1) ES2484690T3 (es)
FR (2) FR2949469A1 (es)
GT (1) GT201200046A (es)
HN (1) HN2012000437A (es)
IL (1) IL218262A0 (es)
MA (1) MA33600B1 (es)
MX (1) MX2012002434A (es)
MY (1) MY157469A (es)
NI (1) NI201200031A (es)
NZ (1) NZ598401A (es)
PE (1) PE20120992A1 (es)
SG (1) SG178537A1 (es)
TN (1) TN2012000053A1 (es)
TW (1) TWI477275B (es)
UA (1) UA106507C2 (es)
UY (1) UY32854A (es)
WO (1) WO2011023883A1 (es)
ZA (1) ZA201201397B (es)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012011900A (es) 2010-04-15 2013-03-21 Seattle Genetics Inc Conjugados de pirrolobenzodiazepina diana.
JP5875083B2 (ja) 2010-04-15 2016-03-02 メディミューン リミテッド 増殖性疾患治療用ピロロベンゾジアゼピン
MX341524B (es) 2011-09-20 2016-08-24 Medimmune Ltd Pirrolobenzodiazepinas como compuestos pbd dimericos asimetricos para inclusion en conjugados dirigidos.
BR112014008981A2 (pt) 2011-10-14 2017-05-02 Spirogen Sàrl pirrolobenzodiazepinas
BR112014008888A2 (pt) 2011-10-14 2017-04-18 Seattle Genetics Inc pirrolobenzodiazepinas
EP3309162A1 (en) 2011-10-14 2018-04-18 Seattle Genetics, Inc. Targeted conjugates of pyrrolobenzodiazepines
ES2687246T3 (es) 2011-10-14 2018-10-24 Seattle Genetics, Inc. Pirrolobenzodiazepinas y conjugados dirigidos
CA2858806A1 (en) 2011-12-23 2013-06-27 Innate Pharma Enzymatic conjugation of polypeptides
US9504756B2 (en) 2012-05-15 2016-11-29 Seattle Genetics, Inc. Self-stabilizing linker conjugates
EA037203B1 (ru) 2012-05-15 2021-02-18 Сиэтл Джинетикс, Инк. Конъюгаты антитело-лекарственное средство с самостабилизирующимися линкерами
EP2872894B1 (en) 2012-07-13 2019-04-17 Innate Pharma Screening of conjugated antibodies
WO2014057072A1 (en) 2012-10-12 2014-04-17 Spirogen Sàrl Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
ES2670937T3 (es) 2012-10-12 2018-06-04 Medimmune Limited Conjugados de anticuerpo-pirrolobenzodiazepina
US10751346B2 (en) 2012-10-12 2020-08-25 Medimmune Limited Pyrrolobenzodiazepine—anti-PSMA antibody conjugates
JP6392763B2 (ja) 2012-10-12 2018-09-19 エイディーシー・セラピューティクス・エス・アーＡｄｃ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｓａ ピロロベンゾジアゼピン−抗体結合体
EP2906297B1 (en) 2012-10-12 2017-12-06 ADC Therapeutics SA Pyrrolobenzodiazepine-antibody conjugates
RS56520B1 (sr) 2012-10-12 2018-02-28 Adc Therapeutics Sa Pirolobenzodiazepin-anti-cd22 konjugati antitela
PT3470086T (pt) 2012-10-12 2021-02-01 Medimmune Ltd Pirrolobenzodiazepinas e conjugados das mesmas
CA2941485C (en) 2012-10-12 2018-06-12 Philip Wilson Howard Pyrrolobenzodiazepines and conjugates thereof
ES2680153T3 (es) 2012-10-12 2018-09-04 Adc Therapeutics Sa Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas
WO2014072482A1 (en) 2012-11-09 2014-05-15 Innate Pharma Recognition tags for tgase-mediated conjugation
EP3441072B1 (en) 2013-03-13 2020-12-30 Seagen Inc. Activated carbon filtration for purification of benzodiazepine adcs
BR112015023070B1 (pt) * 2013-03-13 2022-06-07 Genentech, Inc. Conjugados e compostos de pirrolobenzodiazepinas, composição farmacêutica que compreende os mesmo, bem como seus usos para o tratamento de uma doença proliferativa
JP6340019B2 (ja) 2013-03-13 2018-06-06 メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ ピロロベンゾジアゼピン及びそのコンジュゲート
WO2014140300A1 (en) 2013-03-15 2014-09-18 Innate Pharma Solid phase tgase-mediated conjugation of antibodies
EP3010547B1 (en) 2013-06-20 2021-04-21 Innate Pharma Enzymatic conjugation of polypeptides
KR20160042871A (ko) 2013-06-21 2016-04-20 이나뜨 파르마, 에스.아. 폴리펩티드의 효소적 콘쥬게이션
EP3054986B1 (en) 2013-10-11 2019-03-20 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
EP3054985B1 (en) 2013-10-11 2018-12-26 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
GB201317981D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
EP3054983B1 (en) 2013-10-11 2019-03-20 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
JP6747971B2 (ja) 2013-10-15 2020-08-26 シアトル ジェネティックス， インコーポレイテッド 改善されたリガンド−薬物コンジュゲート薬物動態のためのｐｅｇ化薬物−リンカー
TW202313119A (zh) 2013-12-19 2023-04-01 美商西雅圖遺傳學公司 與標的-藥物結合物併用之亞甲基胺基甲酸酯連接物
CA2938450C (en) 2014-02-11 2023-10-17 Seattle Genetics, Inc. Selective reduction of proteins
WO2016008112A1 (en) 2014-07-16 2016-01-21 Medshine Discovery Inc. Linkers and application towards adc thereof
US9518118B2 (en) 2014-09-12 2016-12-13 Genentech, Inc. Anti-HER2 antibodies and immunoconjugates
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
CA2957148A1 (en) * 2014-09-17 2016-03-24 Genentech, Inc. Immunoconjugates comprising anti-her2 antibodies and pyrrolobenzodiazepines
EP3223854A1 (en) 2014-11-25 2017-10-04 ADC Therapeutics SA Pyrrolobenzodiazepine-antibody conjugates
KR20170102980A (ko) 2015-01-14 2017-09-12 브리스톨-마이어스 스큅 컴퍼니 벤조디아제핀 이량체, 그의 접합체, 및 제조 및 사용 방법
CA2973355A1 (en) 2015-01-14 2016-07-21 Bristol-Myers Squibb Company Heteroarylene-bridged benzodiazepine dimers, conjugates thereof, and methods of making and using
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
JP2018518506A (ja) 2015-06-23 2018-07-12 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 大環状ベンゾジアゼピン二量体、その結合体の製造および使用
MA43345A (fr) 2015-10-02 2018-08-08 Hoffmann La Roche Conjugués anticorps-médicaments de pyrrolobenzodiazépine et méthodes d'utilisation
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
EA201892040A1 (ru) 2016-03-25 2019-04-30 Сиэтл Дженетикс, Инк. Способ получения пегилированных соединений лекарственный препарат - линкер и их промежуточных соединений
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
TW201808343A (zh) 2016-08-09 2018-03-16 美商西雅圖遺傳學公司 具有改善之生理化學性質之具自我穩定連接子之藥物結合物
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
JP7244987B2 (ja) 2016-12-14 2023-03-23 シージェン インコーポレイテッド 多剤抗体薬物コンジュゲート
US11377492B2 (en) 2017-01-24 2022-07-05 Innate Pharma NKp46 binding agents
WO2018141959A1 (en) 2017-02-06 2018-08-09 Innate Pharma Immunomodulatory antibody drug conjugates binding to a human mica polypeptide
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
MX2019009428A (es) 2017-02-08 2019-10-07 Adc Therapeutics Sa Conjugados de pirrolobenzodiazepinas y anticuerpos.
JP2020512312A (ja) 2017-03-24 2020-04-23 シアトル ジェネティックス， インコーポレイテッド グルクロニド薬物−リンカーの調製のためのプロセスおよびその中間体
HUE059828T2 (hu) 2017-04-18 2023-01-28 Medimmune Ltd Pirrolobenzodiazepin konjugátumok
JP7408396B2 (ja) 2017-04-20 2024-01-05 アーデーセー セラピューティクス ソシエテ アノニム 併用療法
BR112019026564A2 (pt) 2017-06-14 2020-06-30 Adc Therapeutics Sa regimes de dosagem para a administração de um adc anti-cd19
LT3668874T (lt) 2017-08-18 2022-03-25 Medimmune Limited Pirolobenzodiazepino konjugatai
CN111164208B (zh) 2017-09-29 2023-08-04 第一三共株式会社 抗体－吡咯并苯并二氮杂卓衍生物偶联物
WO2019092148A1 (en) 2017-11-10 2019-05-16 Innate Pharma Antibodies with functionalized glutamine residues
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) * 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
CN114450324B (zh) 2019-09-26 2024-02-27 日油株式会社 具有肽连接子的异双官能单分散聚乙二醇
BR112022020332A2 (pt) 2020-04-10 2022-12-13 Seagen Inc Composto conjugado anticorpo-droga, composição, método de tratamento de câncer e de um distúrbio autoimune
JP2024501121A (ja) 2020-11-25 2024-01-11 イナート・ファルマ・ソシエテ・アノニム 癌の処置
TW202300179A (zh) 2021-03-18 2023-01-01 美商西根公司 內化的生物活性化合物偶聯物選擇性釋放藥物
EP4308170A1 (en) 2021-03-18 2024-01-24 Seagen Inc. Selective drug release from internalized conjugates of biologically active compounds
WO2023227660A1 (en) 2022-05-25 2023-11-30 Innate Pharma Nectin-4 binding agents

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1516743A (fr) 1966-04-01 1968-02-05 Rhone Poulenc Sa Nouvel antibiotique et son procédé de préparation par culture de streptomyces croceus
GB8307865D0 (en) * 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
GB9205051D0 (en) * 1992-03-09 1992-04-22 Cancer Res Campaign Tech Pyrrolobenzodiazepine derivatives,their preparation,and compositions containing them
KR19990029749A (ko) * 1997-09-17 1999-04-26 미우라 아끼라 2가 반응성 수용성 고분자 유도체 및 이들을 함유하는 복합체
GB9818731D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Compounds
PT1413582E (pt) * 1998-08-27 2006-07-31 Spirogen Ltd Pirrolobenzodiazepinas dimericas
CZ305160B6 (cs) * 2001-06-08 2015-05-27 Ipsen Pharma S.A.S. Chimérické somatostatin-dopaminové analogy
US6716821B2 (en) 2001-12-21 2004-04-06 Immunogen Inc. Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
US7230101B1 (en) 2002-08-28 2007-06-12 Gpc Biotech, Inc. Synthesis of methotrexate-containing heterodimeric molecules
NZ539395A (en) 2002-11-07 2009-01-31 Immunogen Inc Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same
CA2525130C (en) 2003-05-20 2014-04-15 Immunogen, Inc. Improved cytotoxic agents comprising new maytansinoids
NZ580855A (en) 2003-07-21 2012-03-30 Immunogen Inc A CA6 antigen-specific cytotoxic conjugate and methods of using the same
WO2005040170A2 (en) 2003-10-22 2005-05-06 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto
EP1723152B1 (en) 2004-03-09 2015-02-11 Spirogen Sàrl Pyrrolobenzodiazepines
EP1669358A1 (en) 2004-12-07 2006-06-14 Aventis Pharma S.A. Cytotoxic agents comprising new taxanes
US7638491B2 (en) 2004-12-22 2009-12-29 Ambrx, Inc. Therapies using non-natural amino acids and polypeptides
EP1945647B9 (en) * 2005-11-08 2012-11-14 Immunogen, Inc. Processes for preparation of maytansinol
PT1813614E (pt) * 2006-01-25 2012-01-09 Sanofi Sa Agentes citotóxicos compreendendo novos derivados de tomaimicina
EP1832577A1 (en) 2006-03-07 2007-09-12 Sanofi-Aventis Improved prodrugs of CC-1065 analogs
WO2007127440A2 (en) 2006-04-27 2007-11-08 Intezyne Technologies, Inc. Heterofunctional poly(ethylene glycol) containing acid-labile amino protecting groups and uses thereof
EP1864682A1 (en) 2006-06-09 2007-12-12 Sanofi-Aventis Leptomycin derivatives
ZA200900545B (en) * 2006-07-18 2010-03-31 Sanofi Aventis Antagonist antibody against EPHA2 for the treatment of cancer
EP1914242A1 (en) 2006-10-19 2008-04-23 Sanofi-Aventis Novel anti-CD38 antibodies for the treatment of cancer
PL2019104T3 (pl) * 2007-07-19 2014-03-31 Sanofi Sa Środki cytotoksyczne obejmujące nowe pochodne tomaymycyny i ich zastosowanie terapeutyczne
EP2185188B1 (en) 2007-08-22 2014-08-06 Medarex, L.L.C. Site-specific attachment of drugs or other agents to engineered antibodies with c-terminal extensions
SG189817A1 (en) * 2008-04-30 2013-05-31 Immunogen Inc Potent conjugates and hydrophilic linkers
CA3014224C (en) * 2009-02-05 2022-05-24 Immunogen, Inc. Condensed benzodiazepine-indoline derivatives and processes to prepare said derivatives
UY32913A (es) * 2009-10-02 2011-04-29 Sanofi Aventis Nuevos maitansinoides y el uso de dichos maitansinoides para preparar conjugados con un anticuero
FR2963007B1 (fr) * 2010-07-26 2013-04-05 Sanofi Aventis Derives anticancereux, leur preparation et leur application therapeutique

Also Published As

Publication number Publication date
AU2010288382B2 (en) 2015-10-22
EA201270308A1 (ru) 2013-01-30
MX2012002434A (es) 2012-07-20
CA2772102C (fr) 2018-09-04
ECSP12011688A (es) 2012-03-30
CN102753559A (zh) 2012-10-24
AU2010288382A1 (en) 2012-03-15
AR078143A1 (es) 2011-10-19
ES2484690T3 (es) 2014-08-12
IL218262A0 (en) 2012-04-30
UA106507C2 (uk) 2014-09-10
JP2013503143A (ja) 2013-01-31
TW201119657A (en) 2011-06-16
NZ598401A (en) 2014-03-28
SG178537A1 (en) 2012-03-29
US20140155590A1 (en) 2014-06-05
CL2012000489A1 (es) 2012-08-03
KR20130026405A (ko) 2013-03-13
BR112012004146A2 (pt) 2017-05-30
CA2772102A1 (fr) 2011-03-03
JP5889189B2 (ja) 2016-03-22
CO6612210A2 (es) 2013-02-01
FR2949470B1 (fr) 2011-11-04
CR20120085A (es) 2012-06-01
EP2470547B1 (fr) 2014-05-14
FR2949469A1 (fr) 2011-03-04
PE20120992A1 (es) 2012-08-22
ZA201201397B (en) 2013-05-29
DOP2012000038A (es) 2012-06-15
MA33600B1 (fr) 2012-09-01
FR2949470A1 (fr) 2011-03-04
WO2011023883A1 (fr) 2011-03-03
EA026488B1 (ru) 2017-04-28
MY157469A (en) 2016-06-15
EP2470547A1 (fr) 2012-07-04
CN102753559B (zh) 2015-11-25
CL2013001609A1 (es) 2013-11-04
GT201200046A (es) 2014-09-26
TWI477275B (zh) 2015-03-21
US20120244172A1 (en) 2012-09-27
US8481042B2 (en) 2013-07-09
NI201200031A (es) 2013-09-18
UY32854A (es) 2011-03-31
TN2012000053A1 (fr) 2013-09-19

Similar Documents

Publication Publication Date Title
HN2012000437A (es) Nuevos agentes anticancer y la preparacion de dichos agentes
JOP20180102B1 (ar) مركب صيدلاني
DOP2006000096A (es) Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion
EA201401254A1 (ru) Самостабилизирующиеся линкерные конъюгаты
HN2008001191A (es) Compuestos de biciclolactama sustituida
PE20160190A1 (es) Anticuerpos anti-fgfr2iiib afucosilados
UY31562A1 (es) Azolilmetiloxiranos, su uso y agentes que los contienen
UY31560A1 (es) Azolilmetiloxiranos, su uso y agentes que los contienen
BR112015028674A2 (pt) composição detergente compacta fluida para lavagem de roupas
UY31688A1 (es) Plaguicidas
MA44550A1 (fr) Anticorps anti-acide téichoique de la paroi cellulaire et conjugués associés
UY29361A1 (es) Pirroles e imidazoles sustituídos, composiciones que los contienen, procedimiento de fabricación y utilización
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
HN2010001537A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
UA107671C2 (en) N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
CO6321288A2 (es) Sales de compuestos inhibidores de vih
UY31128A1 (es) Formulacion de nevirapina de liberacion prolongada
HN2009000856A (es) Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
HN2012001262A (es) Nuevos derivados de 8heterociclo-piperidina condensada)-( piperazinil)-1-alcanona o de (heterociclo-pirrolidina condensada)-(piperazinil)-1-alcanona y su utilizacion como inhibidores de p75
MA32461B1 (fr) Dronedarone pour la prevention de cardioversion
ATE533477T1 (de) Pharmazeutische zusammensetzungen enthaltend irbesartan
BR112013000941A2 (pt) formulações de 14-epi-análogos de vitamina d
HK1151718A1 (en) Flupentixol compositions
UY32515A (es) Nuevos derivados anticancerosos de nicotinamida, su preparación y su aplicación terapéutica
MA33932B1 (fr) Dérivés de 2-aldoximino-5-fluoropyrimidine